Connect with us

Government

Best Stocks To Buy Now? 5 Health Care Stocks In Focus

Could these health care stocks be the remedy to investors’ recent stock market pains?
The post Best Stocks To Buy Now? 5 Health Care Stocks In Focus…

Published

on

5 Top Health Care Stocks To Add To Your Radar This Week

For investors wondering why are stocks tanking in the stock market now, health care stocks could be worth looking at. On the whole, the ever-vital health care industry has and continues to play crucial roles during the coronavirus pandemic. From the more obvious vaccine-making names to the day-to-day health care providers, this is apparent. Even as the world aims to transition towards endemic living, there is more focus on health care now than ever. As people attempt to stay healthy amidst these trying times, investors could be considering jumping into this defensive sector in the stock market today.

For one thing, some of the top players in the health care scene today continue to draw attention. Namely, the likes of BioNTech (NASDAQ: BNTX) are among the industry players gaining attention this week. To point out, BioNTech’s latest quarterly earnings update seems to be turning heads across the board. In it, the coronavirus vaccine firm saw its revenue soar by 211% year-over-year. This would be thanks to sales from its coronavirus shot jointly developed with Pfizer (NYSE: PFE). All in all, the health care industry continues to power on despite the additional pressure from the endemic. On that note, here are five more to watch today.

Health Care Stocks To Buy [Or Sell] Today

Moderna Inc.

biotech stocks (MRNA stock)

Starting us off today, we have Moderna, a biopharmaceutical company that continues to advance programs in the field of messenger RNA (mRNA). In fact, the company has a pipeline of vaccines in the works after the huge success of its coronavirus vaccine. This would include an influenza and HIV vaccine that could prove to be game-changing as well. Last week, the company reported its first-quarter financials for 2022.

Diving in, it generated $6.1 billion in revenue, compared to $1.9 billion a year earlier. This increase is primarily due to the increase in its coronavirus vaccine sales.Net income for the quarter was $3.7 billion or a diluted earnings per share of $8.58. The company also ended the quarter with $19.3 billion in cash. “Beginning in the fall of 2022, our robust Phase 3 pipeline could lead to three respiratory commercial launches over the next two to three years. We also look forward to advancing our therapeutic programs and sharing proof-of-concept readouts on our rare genetic disease programs for propionic acidemia and methylmalonic acidemia, and on our personalized cancer vaccine program this year,” said Stéphane Bancel, Chief Executive Officer of Moderna. Given the impressive quarter, is MRNA stock worth investing in right now?

[Read More] Stock Market Today: Dow Jones, S&P 500 Tumbles; Palantir Stock Down On Mixed Earnings

Veru Inc.

top biotech stocks (VERU stock)

Veru is a biopharmaceutical company that develops novel medicines for the coronavirus and other viral diseases. It also develops treatments for breast and prostate cancers. Notably, its Sabizabulin drug has dual antiviral and anti-inflammatory effects. It is also being developed as a potential treatment for hospitalized coronavirus patients at high risk for acute respiratory distress syndrome. On May 2, 2022, the company announced that the FDA has granted the company a pre-emergency use authorization meeting on May 10, 2022, for the positive Phase 3 study for Sabizabulin.

Its findings indicate positive efficacy and safety results from a double-blind, randomized placebo-controlled trial. In the trial, it was shown that the drug candidate could reduce deaths by 55% in hospitalized patients. The Independent Data Safety Monitoring Committee unanimously recommended that the Phase 3 study be halted early due to efficacy, and they further remarked that no safety concerns were identified. Given this exciting piece of news, should you consider adding VERU stock to your portfolio?

Biogen Inc.

top health care stocks (BIIB stock)

Biogen is a health care company that develops innovative therapies for people living with serious neurological diseases worldwide. Accordingly, it is one of the world’s first global biotechnology companies and continues to be a leading health care company with its portfolio of treatments. The company is also commercializing biosimilars and is focusing on its neuroscience pipeline.

Last week, the company announced together with MedRhythms that they will develop and commercialize MR-004, an investigational prescription digital therapeutic for the potential treatment of gait deficits in multiple sclerosis (MS). The collaboration combines MedRhythms’ digital expertise with Biogen’s leadership in MS to address significant unmet patient needs. If approved, MR-004 has the potential to become the first prescription digital therapeutic for gait deficit in MS. With that being said, is BIIB stock a buy?

[Read More] Gaming Stocks To Invest In Right Now? 5 Names To Know

Novavax Inc.

best biotech stocks (NVAX stock)

Another health care name to take note of in the stock market today would be Novavax. Overall, the biotech company specializes in the development of vaccines for serious infectious diseases. The like of which range from Ebola, influenza, respiratory syncytial viruses, and COVID-19, to name a few. For investors keen to jump on upcoming names in the coronavirus vaccine space, NVAX stock could be a viable play.

Speaking of its coronavirus shot, Novavax appears to be firing on all cylinders on this front. Just last week, the company made two key regulatory submissions. Firstly, on May 6, Novavax applied to expand the use of its vaccine in Australian and New Zealand teens aged 12 to 17 years. Secondly, the company made a similar application in Britain for adolescents aged 12 and older earlier in the week. With Novavax’s current momentum in mind, will you be keeping an eye on NVAX stock?

[Read More] 4 Top Oil Stocks To Watch In The Stock Market Today

UnitedHealth Group Inc.

best health care stocks to buy now (UNH stock)

Topping off our list today is the UnitedHealth Group or UNH, for short. In brief, UNH is a multinational managed health care and insurance firm. As you can imagine the company primarily offers consumers health care solutions and insurance services. For a sense of scale, UNH serves 148 million individuals via its partnerships with governments, employers, and health care providers. Because of all this, investors looking for more defensive names in the health care space may be considering UNH stock.

On the whole, the company appears to be going strong on the operational front as well. Just last month, UNH beat Wall Street’s estimates at the top and bottom line in its latest quarterly earnings release. Getting straight to it, the company is looking at earnings of $5.49 on revenue of $1.33 billion. For revenue, UNH is boasting commendable year-over-year gains of 14%. This, according to the company, is thanks to double-digit growth across its core Optum and UnitedHealthcare sections. This alongside UNH raising its full-year outlook would suggest that the company is not slowing down anytime soon. As such, would UNH stock be a top pick in your books?

If you enjoyed this article and you’re interested in learning how to trade so you can have the best chance to profit consistently then you need to checkout this YouTube channel. CLICK HERE RIGHT NOW!!

The post Best Stocks To Buy Now? 5 Health Care Stocks In Focus appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.

Read More

Continue Reading

Government

Low Iron Levels In Blood Could Trigger Long COVID: Study

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate…

Published

on

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate iron levels in their blood due to a COVID-19 infection could be at greater risk of long COVID.

(Shutterstock)

A new study indicates that problems with iron levels in the bloodstream likely trigger chronic inflammation and other conditions associated with the post-COVID phenomenon. The findings, published on March 1 in Nature Immunology, could offer new ways to treat or prevent the condition.

Long COVID Patients Have Low Iron Levels

Researchers at the University of Cambridge pinpointed low iron as a potential link to long-COVID symptoms thanks to a study they initiated shortly after the start of the pandemic. They recruited people who tested positive for the virus to provide blood samples for analysis over a year, which allowed the researchers to look for post-infection changes in the blood. The researchers looked at 214 samples and found that 45 percent of patients reported symptoms of long COVID that lasted between three and 10 months.

In analyzing the blood samples, the research team noticed that people experiencing long COVID had low iron levels, contributing to anemia and low red blood cell production, just two weeks after they were diagnosed with COVID-19. This was true for patients regardless of age, sex, or the initial severity of their infection.

According to one of the study co-authors, the removal of iron from the bloodstream is a natural process and defense mechanism of the body.

But it can jeopardize a person’s recovery.

When the body has an infection, it responds by removing iron from the bloodstream. This protects us from potentially lethal bacteria that capture the iron in the bloodstream and grow rapidly. It’s an evolutionary response that redistributes iron in the body, and the blood plasma becomes an iron desert,” University of Oxford professor Hal Drakesmith said in a press release. “However, if this goes on for a long time, there is less iron for red blood cells, so oxygen is transported less efficiently affecting metabolism and energy production, and for white blood cells, which need iron to work properly. The protective mechanism ends up becoming a problem.”

The research team believes that consistently low iron levels could explain why individuals with long COVID continue to experience fatigue and difficulty exercising. As such, the researchers suggested iron supplementation to help regulate and prevent the often debilitating symptoms associated with long COVID.

It isn’t necessarily the case that individuals don’t have enough iron in their body, it’s just that it’s trapped in the wrong place,” Aimee Hanson, a postdoctoral researcher at the University of Cambridge who worked on the study, said in the press release. “What we need is a way to remobilize the iron and pull it back into the bloodstream, where it becomes more useful to the red blood cells.”

The research team pointed out that iron supplementation isn’t always straightforward. Achieving the right level of iron varies from person to person. Too much iron can cause stomach issues, ranging from constipation, nausea, and abdominal pain to gastritis and gastric lesions.

1 in 5 Still Affected by Long COVID

COVID-19 has affected nearly 40 percent of Americans, with one in five of those still suffering from symptoms of long COVID, according to the U.S. Centers for Disease Control and Prevention (CDC). Long COVID is marked by health issues that continue at least four weeks after an individual was initially diagnosed with COVID-19. Symptoms can last for days, weeks, months, or years and may include fatigue, cough or chest pain, headache, brain fog, depression or anxiety, digestive issues, and joint or muscle pain.

Tyler Durden Sat, 03/09/2024 - 12:50

Read More

Continue Reading

Government

Walmart joins Costco in sharing key pricing news

The massive retailers have both shared information that some retailers keep very close to the vest.

Published

on

As we head toward a presidential election, the presumed candidates for both parties will look for issues that rally undecided voters. 

The economy will be a key issue, with Democrats pointing to job creation and lowering prices while Republicans will cite the layoffs at Big Tech companies, high housing prices, and of course, sticky inflation.

The covid pandemic created a perfect storm for inflation and higher prices. It became harder to get many items because people getting sick slowed down, or even stopped, production at some factories.

Related: Popular mall retailer shuts down abruptly after bankruptcy filing

It was also a period where demand increased while shipping, trucking and delivery systems were all strained or thrown out of whack. The combination led to product shortages and higher prices.

You might have gone to the grocery store and not been able to buy your favorite paper towel brand or find toilet paper at all. That happened partly because of the supply chain and partly due to increased demand, but at the end of the day, it led to higher prices, which some consumers blamed on President Joe Biden's administration.

Biden, of course, was blamed for the price increases, but as inflation has dropped and grocery prices have fallen, few companies have been up front about it. That's probably not a political choice in most cases. Instead, some companies have chosen to lower prices more slowly than they raised them.

However, two major retailers, Walmart (WMT) and Costco, have been very honest about inflation. Walmart Chief Executive Doug McMillon's most recent comments validate what Biden's administration has been saying about the state of the economy. And they contrast with the economic picture being painted by Republicans who support their presumptive nominee, Donald Trump.

Walmart has seen inflation drop in many key areas.

Image source: Joe Raedle/Getty Images

Walmart sees lower prices

McMillon does not talk about lower prices to make a political statement. He's communicating with customers and potential customers through the analysts who cover the company's quarterly-earnings calls.

During Walmart's fiscal-fourth-quarter-earnings call, McMillon was clear that prices are going down.

"I'm excited about the omnichannel net promoter score trends the team is driving. Across countries, we continue to see a customer that's resilient but looking for value. As always, we're working hard to deliver that for them, including through our rollbacks on food pricing in Walmart U.S. Those were up significantly in Q4 versus last year, following a big increase in Q3," he said.

He was specific about where the chain has seen prices go down.

"Our general merchandise prices are lower than a year ago and even two years ago in some categories, which means our customers are finding value in areas like apparel and hard lines," he said. "In food, prices are lower than a year ago in places like eggs, apples, and deli snacks, but higher in other places like asparagus and blackberries."

McMillon said that in other areas prices were still up but have been falling.

"Dry grocery and consumables categories like paper goods and cleaning supplies are up mid-single digits versus last year and high teens versus two years ago. Private-brand penetration is up in many of the countries where we operate, including the United States," he said.

Costco sees almost no inflation impact

McMillon avoided the word inflation in his comments. Costco  (COST)  Chief Financial Officer Richard Galanti, who steps down on March 15, has been very transparent on the topic.

The CFO commented on inflation during his company's fiscal-first-quarter-earnings call.

"Most recently, in the last fourth-quarter discussion, we had estimated that year-over-year inflation was in the 1% to 2% range. Our estimate for the quarter just ended, that inflation was in the 0% to 1% range," he said.

Galanti made clear that inflation (and even deflation) varied by category.

"A bigger deflation in some big and bulky items like furniture sets due to lower freight costs year over year, as well as on things like domestics, bulky lower-priced items, again, where the freight cost is significant. Some deflationary items were as much as 20% to 30% and, again, mostly freight-related," he added.

Read More

Continue Reading

Government

Walmart has really good news for shoppers (and Joe Biden)

The giant retailer joins Costco in making a statement that has political overtones, even if that’s not the intent.

Published

on

As we head toward a presidential election, the presumed candidates for both parties will look for issues that rally undecided voters. 

The economy will be a key issue, with Democrats pointing to job creation and lowering prices while Republicans will cite the layoffs at Big Tech companies, high housing prices, and of course, sticky inflation.

The covid pandemic created a perfect storm for inflation and higher prices. It became harder to get many items because people getting sick slowed down, or even stopped, production at some factories.

Related: Popular mall retailer shuts down abruptly after bankruptcy filing

It was also a period where demand increased while shipping, trucking and delivery systems were all strained or thrown out of whack. The combination led to product shortages and higher prices.

You might have gone to the grocery store and not been able to buy your favorite paper towel brand or find toilet paper at all. That happened partly because of the supply chain and partly due to increased demand, but at the end of the day, it led to higher prices, which some consumers blamed on President Joe Biden's administration.

Biden, of course, was blamed for the price increases, but as inflation has dropped and grocery prices have fallen, few companies have been up front about it. That's probably not a political choice in most cases. Instead, some companies have chosen to lower prices more slowly than they raised them.

However, two major retailers, Walmart (WMT) and Costco, have been very honest about inflation. Walmart Chief Executive Doug McMillon's most recent comments validate what Biden's administration has been saying about the state of the economy. And they contrast with the economic picture being painted by Republicans who support their presumptive nominee, Donald Trump.

Walmart has seen inflation drop in many key areas.

Image source: Joe Raedle/Getty Images

Walmart sees lower prices

McMillon does not talk about lower prices to make a political statement. He's communicating with customers and potential customers through the analysts who cover the company's quarterly-earnings calls.

During Walmart's fiscal-fourth-quarter-earnings call, McMillon was clear that prices are going down.

"I'm excited about the omnichannel net promoter score trends the team is driving. Across countries, we continue to see a customer that's resilient but looking for value. As always, we're working hard to deliver that for them, including through our rollbacks on food pricing in Walmart U.S. Those were up significantly in Q4 versus last year, following a big increase in Q3," he said.

He was specific about where the chain has seen prices go down.

"Our general merchandise prices are lower than a year ago and even two years ago in some categories, which means our customers are finding value in areas like apparel and hard lines," he said. "In food, prices are lower than a year ago in places like eggs, apples, and deli snacks, but higher in other places like asparagus and blackberries."

McMillon said that in other areas prices were still up but have been falling.

"Dry grocery and consumables categories like paper goods and cleaning supplies are up mid-single digits versus last year and high teens versus two years ago. Private-brand penetration is up in many of the countries where we operate, including the United States," he said.

Costco sees almost no inflation impact

McMillon avoided the word inflation in his comments. Costco  (COST)  Chief Financial Officer Richard Galanti, who steps down on March 15, has been very transparent on the topic.

The CFO commented on inflation during his company's fiscal-first-quarter-earnings call.

"Most recently, in the last fourth-quarter discussion, we had estimated that year-over-year inflation was in the 1% to 2% range. Our estimate for the quarter just ended, that inflation was in the 0% to 1% range," he said.

Galanti made clear that inflation (and even deflation) varied by category.

"A bigger deflation in some big and bulky items like furniture sets due to lower freight costs year over year, as well as on things like domestics, bulky lower-priced items, again, where the freight cost is significant. Some deflationary items were as much as 20% to 30% and, again, mostly freight-related," he added.

Read More

Continue Reading

Trending